1. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival
   Sara Massironi et al, 2016, Oncotarget CrossRef
2. Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
   Guopei Luo et al, 2017, Oncology Letters CrossRef
3. Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
   Guopei Luo et al, 2017, Oncology Letters CrossRef
4. Usefulness of 18F‐FDG‐PET/CT in the diagnosis and prediction of recurrence of pancreatic neuroendocrine neoplasms
   Asahi Sato et al, 2020, Journal of Hepato-Biliary-Pancreatic Sciences CrossRef
5. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center
   Guopei Luo et al, 2015, Pancreatology CrossRef
6. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
   Diletta Calabrò et al, 2020, Diagnostics CrossRef
7. Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms
   Roberta MODICA et al, 2024, Minerva Endocrinology CrossRef
8. Recent advances in gene therapy for cancer theranostics
   Hannah J. Vaughan et al, 2021, Current Opinion in Biomedical Engineering CrossRef
9. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC)
   LIANG LIU et al, 2016, International Journal of Oncology CrossRef
10. Novel PET tracers: added value for endocrine disorders
    Sébastien Bergeret et al, 2019, Endocrine CrossRef
11. The utility of 18F-FDG PET/CT in the diagnosis, staging of non-functioning pancreatic neuroendocrine tumors
    Gihan Hassan Gamal, 2021, Egyptian Journal of Radiology and Nuclear Medicine CrossRef
12. The Utility of 68 Ga-DOTATATE Positron-Emission Tomography/Computed Tomography in the Diagnosis, Management, Follow-Up and Prognosis of Neuroendocrine Tumors
    Amit Tirosh et al, 2018, Future Oncology CrossRef
13. FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer
    Shunrong Ji et al, 2016, Clinical Cancer Research CrossRef
14. Gastroenteropancreatic Neuroendocrine Neoplasms
    Mohsen Beheshti et al, 2018, PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging CrossRef